Immunomodulation of asthma: where do we stand?

Curr Allergy Asthma Rep. 2002 Nov;2(6):433-5. doi: 10.1007/s11882-002-0078-y.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Asthma / genetics
  • Asthma / immunology*
  • Asthma / therapy*
  • Cytokines / antagonists & inhibitors
  • Humans
  • Hypersensitivity / genetics
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy
  • Immunoglobulin E / immunology
  • Omalizumab
  • Receptors, Interleukin / antagonists & inhibitors
  • Vaccines, DNA / therapeutic use

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • Receptors, Interleukin
  • Vaccines, DNA
  • Omalizumab
  • Immunoglobulin E